- Home
- HIHO vs PHIO Comparison
HIHO vs PHIO Comparison
Compare HIHO & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- PHIO
- Stock Information
- Founded
- HIHO 1990
- PHIO 2011
- Country
- HIHO Hong Kong
- PHIO United States
- Employees
- HIHO N/A
- PHIO N/A
- Industry
- HIHO Industrial Machinery/Components
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- HIHO Industrials
- PHIO Health Care
- Exchange
- HIHO Nasdaq
- PHIO Nasdaq
- Market Cap
- HIHO 8.3M
- PHIO 8.6M
- IPO Year
- HIHO 1996
- PHIO N/A
- Fundamental
- Price
- HIHO $1.75
- PHIO $2.96
- Analyst Decision
- HIHO
- PHIO Strong Buy
- Analyst Count
- HIHO 0
- PHIO 2
- Target Price
- HIHO N/A
- PHIO $9.00
- AVG Volume (30 Days)
- HIHO 29.3K
- PHIO 701.6K
- Earning Date
- HIHO 07-31-2025
- PHIO 05-15-2025
- Dividend Yield
- HIHO 6.86%
- PHIO N/A
- EPS Growth
- HIHO N/A
- PHIO N/A
- EPS
- HIHO N/A
- PHIO N/A
- Revenue
- HIHO $7,345,000.00
- PHIO N/A
- Revenue This Year
- HIHO N/A
- PHIO N/A
- Revenue Next Year
- HIHO N/A
- PHIO N/A
- P/E Ratio
- HIHO N/A
- PHIO N/A
- Revenue Growth
- HIHO 11.36
- PHIO N/A
- 52 Week Low
- HIHO $1.40
- PHIO $0.97
- 52 Week High
- HIHO $2.88
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- HIHO 48.71
- PHIO 77.11
- Support Level
- HIHO $1.73
- PHIO $1.71
- Resistance Level
- HIHO $1.81
- PHIO $2.08
- Average True Range (ATR)
- HIHO 0.06
- PHIO 0.18
- MACD
- HIHO -0.01
- PHIO 0.09
- Stochastic Oscillator
- HIHO 8.00
- PHIO 84.46
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.